(NBIX) Neurocrine Biosciences - Performance -15.3% in 12m

Compare NBIX with Indices, Sectors and Commodities and Bonds. Who performs better in which timeframe?

Performance Rating 1.91%
#34 in Peer-Group
Rel. Strength 30.64%
#5304 in Stock-Universe
Total Return 12m -15.30%
#55 in Peer-Group
Total Return 5y -3.33%
#38 in Peer-Group
P/E Value
P/E Trailing 39.2
P/E Forward 23.6
High / Low USD
52 Week High 153.29 USD
52 Week Low 87.54 USD
Sentiment Value
VRO Trend Strength +-100 85.29
Buy/Sell Signal +-5 0.93
Support / Resistance Levels
Support
Resistance
12m Total Return: NBIX (-15.3%) vs XBI (-16.1%)
Total Return of Neurocrine Biosciences versus its related sector ETF XBI
5y Drawdown (Underwater) Chart
5 Year Drawdown / Underwater Chart for (NBIX) Neurocrine Biosciences - Performance -15.3% in 12m

Top Performer in Biotechnology

Short Term Performance

Symbol 1w 1m 3m
NBIX 2.34% 25.1% 5.53%
RGLS 0.0% 303% 523%
CTMX 83.5% 217% 152%
CRVO -2.92% -11.6% 287%

Long Term Performance

Symbol 6m 12m 5y
NBIX 2.41% -15.3% -3.33%
RGC 6,458% 7,619% 3,729%
DRUG -18.3% 2,882% 19.9%
MNPR 119% 1,223% 0.64%

Overall best picks of Peer Group - Selected by proven GARP Predictive Metrics, sorted by Growth Rating

Symbol 1m 12m 5y P/E P/E Forward PEG EPS Stability EPS CAGR
ABBV NYSE
AbbVie
2.76% 15% 144% 84.8 16.3 0.42 -26.0% 14.2%
UTHR NASDAQ
United Therapeutics
6.71% 11.5% 155% 12.4 11 1.43 74.6% 16.1%
GILD NASDAQ
Gilead Sciences
-5.05% 55.4% 64.3% 20.4 12.2 0.2 28.0% -3.71%
AMGN NASDAQ
Amgen
-8% -12.3% 35% 24.7 13 0.9 0.60% 41%
LONN SW
Lonza
5.88% 7.55% 26.2% 65.7 36 1.31 2.20% -12.5%
BIM PA
Biomerieux
- 24.9% -3% 32.5 25.2 1.52 -38.5% -25.1%
KMDA NASDAQ
Kamada
9.06% 26.2% 1.24% 27.5 25.1 1 32.5% 3.93%
NBIX NASDAQ
Neurocrine Biosciences
25.1% -15.3% -3.33% 39.2 23.6 0.27 18.7% -34.3%

Performance Comparison: NBIX vs XBI vs S&P 500

XBI (SPDR S&P Biotech ETF) is the Sector Benchmark for NBIX
Total Return (including Dividends) NBIX XBI S&P 500
1 Month 25.07% 1.36% 9.83%
3 Months 5.53% -15.05% -3.15%
12 Months -15.30% -16.10% 12.87%
5 Years -3.33% -26.28% 115.27%

Trend Score (consistency of price movement) NBIX XBI S&P 500
1 Month 92.7% 5.6% 97.1%
3 Months -22.7% -77.9% -46.6%
12 Months -58.9% -58.5% 47.9%
5 Years 51.7% -54% 84.1%

Relative Strength (compared with Indexes) Rank in Peer Group vs. XBI vs. S&P 500
1 Month #29 23.40% 13.88%
3 Month #25 24.22% 8.96%
12 Month #56 0.96% -24.96%
5 Years #37 31.13% -55.09%

FAQs

Does Neurocrine Biosciences (NBIX) outperform the market?

Yes, over the last 12 months NBIX made -15.30%, while its related Sector, the SPDR S&P Biotech (XBI) made -16.10%. Over the last 3 months NBIX made 5.53%, while XBI made -15.05%.

Performance Comparison NBIX vs Indeces and Sectors

Above 0 means better perfomance compared to Symbol in this Timeframe

NBIX vs. Indices

Symbol 1w 1m 6m 12m
US S&P 500 SPY -2.2% 15.2% 1% -28%
US NASDAQ 100 QQQ -4% 11.7% -2.5% -31%
German DAX 40 DAX 1.1% 13.9% -20.5% -40%
Shanghai Shenzhen CSI 300 CSI 300 0.3% 18.8% 2.7% -24%
Hongkong Hang Seng HSI -0.8% 10.1% -9.2% -26%
India NIFTY 50 INDA -3.9% 18% -1.6% -21%
Brasil Bovespa EWZ 0.4% 12.4% -4.9% -11%

NBIX vs. Sectors

Symbol 1w 1m 6m 12m
Communication Services XLC -1.2% 15.3% -4.4% -39%
Consumer Discretionary XLY -4.7% 10.9% 0.9% -37%
Consumer Staples XLP 2.6% 24.9% -0.4% -23%
Energy XLE -2.6% 16.8% 10.6% -9%
Financial XLF -0.5% 16.6% -1.2% -39%
Health Care XLV 5.1% 30.3% 9.7% -6%
Industrial XLI -2.2% 12.6% -0.6% -30%
Materials XLB 0.2% 18.5% 7.1% -11%
Real Estate XLRE 2% 20.9% 4.2% -26%
Technology XLK -5.3% 8.4% -0.5% -26%
Utilities XLU 1.2% 20.8% -1.4% -30%
Aerospace & Defense XAR -2.3% 10.8% -11.6% -47%
Biotech XBI 2.9% 23.7% 17.9% 1%
Homebuilder XHB -0.2% 16.2% 16.2% -6%
Retail XRT -3.7% 10.2% 5.4% -14%

NBIX vs. Commodities

Symbol 1w 1m 6m 12m
Oil USO -0.7% 23.4% 5.51% -4%
Natural Gas UNG 9.4% 28.3% -23.2% -11%
Gold GLD 4.6% 25.1% -23.5% -50%
Silver SLV 1.8% 24.4% -5% -24%
Copper CPER -0.1% 24.2% -11.9% -13%

NBIX vs. Bonds

Symbol 1w 1m 6m 12m
iShares 20+ Years Bond TLT 3.3% 26.7% 4.8% -13%
iShares High Yield Corp. Bond HYG 1.3% 22% -0.7% -24%